Gestational trophoblastic disease: A 21-year review of the clinical experience at an Argentinean public hospital

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 57, Issue 4, 2012, Pages 341-349

  Bianconi, María Inés ^a,b   Otero, Silvina ^a,b   Moscheni, Oriana ^a,b   Alvarez, Lucia ^a,b   Storino, Claudio ^a,b   Jankilevich, Gustavo ^a,b  

^a Clinical Oncology Unit   (Argentina)

^b HOSPITAL DURAND   (Argentina)

Author keywords

Choriocarcinoma; Gestational trophoblastic disease; Gestational trophoblastic neoplasia

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; CARBOPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; FOLINIC ACID; GEMCITABINE; IFOSFAMIDE; MESNA; METHOTREXATE; PACLITAXEL; VINBLASTINE; VINCRISTINE; VINCRISTINE SULFATE;

ADULT; ALOPECIA; ARGENTINA; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RELAPSE; CHRONIC KIDNEY FAILURE; DRY EYE; FEMALE; GOVERNMENT; HEALTH CARE POLICY; HOSPITAL ADMISSION; HUMAN; HYDATIDIFORM MOLE; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROPATHY; PATIENT REFERRAL; PRIORITY JOURNAL; PUBLIC HOSPITAL; RELAPSE; SALVAGE THERAPY; SCORING SYSTEM; STOMATITIS; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; TROPHOBLASTIC TUMOR; TUMOR REGRESSION; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARGENTINA; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; FEMALE; GESTATIONAL TROPHOBLASTIC DISEASE; HOSPITALS, PUBLIC; HUMANS; HYSTERECTOMY; LEUCOVORIN; LONGITUDINAL STUDIES; METHOTREXATE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; PREGNANCY; REMISSION, SPONTANEOUS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SALVAGE THERAPY; UTERINE NEOPLASMS; VACUUM CURETTAGE; VINCRISTINE; YOUNG ADULT;

EID: 84866097244     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Bagshawe KD: Risk and prognostic factors in trophoblastic neoplasia. Cancer 1976;38:1373-1385
2. WHO Scientific Group on Gestational Trophoblastic Disease: Gestational Trophoblastic Diseases Technical Report Series No. 692, Geneva, WHO, 1983
3. DuBeshter B, Berkowitz RS, Goldstein DP, et al: Metastatic gestational trophoblastic disease: Experience at the New England in Trophoblastic Disease Cancer 1965-1985. Obstet Gynecol 1987;69:390-395
4. Goldfarb A, Bianconi MI, Otero S., et al: Protocolo manejo multidisciplinario de la enfermedad trofoblastica gestacional (ETG). Revista Oncologia Clinica, 2001, volumen 6, trabajos en Ginecologia (seccion 9) trabajo no 10 http://www.aaoc.org.ar
5. Kohorn EI, Goldstein DP, Hancock BW: Continuing the staging system of the International Federation of Gynecology and Obstetrics with the scoring system of the World Health Organization for trophoblastic neoplasm: Report of the Working Committee of the International Society for the Study of Trophoblastic Disease and the International Gynecological Cancer Society. Int J Gynecol Cancer 2000;10:84-88
6. Kohorn EI: The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: Description and critical assessment. Int J Gyn Cancer 2000;11:73
7. Kohorn EI: Evaluation of the criteria used to make the diagnosis of non-metastatic gestational trophoblastic neoplasia. Gynecol Oncol 1993;48:139-147
8. Soper JT: Identification and management of high-risk gestational trophoblastic disease. Semin Oncol 1995;22:172-184
9. Benedet JL, Hacker NF: FIGO Committee on Gynecologic Oncology. Guidelines committee. Second edition. 2004, pp 122-145
10. Goldstein DP, Berkowitz RS: Prophylactic chemotherapy of complete molar pregnancy. Semin Oncol 1995;22:157-160
11. Kohorn EI: Single agent chemotherapy for non metastatic gestational trophoblastic neoplasia. J Reprod Med 1991;36: 49-53
12. Sekharan PK, Sreedevi NS, Radhadevi VP, et al: Management of postmolar gestational trophoblastic disease with methotrexate and folinic acid: 15 years of experience. J Reprod Med 2006;10:835-840
13. Howard J: Development of single-agent chemotherapy regimen in gestational trophoblastic disease. J Reprod Med 1994; 39:185-192
14. Surwit E: High-risk metastatic gestational trophoblastic disease. J Reprod Med 1991;36:105-109
15. Newlands ES: New chemotherapeutic agents in management of gestational trophoblastic disease. Gynecol Oncol 1979;8:296-299
16. Lurain JR: Management of high-risk gestational trophoblastic disease. J Reprod Med 1998;43:44-52
17. Newlands ES, Mulholland L, Holden L, et al: Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol 2000;8:854-859
18. Newlands ES, Bower M, Holden L, et al: Management of resistant gestational trophoblastic tumors. J Reprod Med 1998; 43:111-118
19. DuBeshter B, Berkowitz RS, Goldstein DP, et al: Management of low-risk metastatic gestational trophoblastic tumors. J Reprod Med 1991;36:36-39
20. Lurain JR: High-risk metastatic gestational trophoblastic tumors: Current management. J Reprod Med 1994;39:217-232
21. Bagshawe KD: Treatment of high-risk choriocarcinoma. J Reprod Med 1984;29:813-820
22. Kim SJ, Bae SN, Kim JH, et al: Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen. Gynecol Oncol 1998;71:247-253
23. Newlands ES: Results and toxicity using PE/EMA schedule in patients with gestational trophoblastic tumors. ASCO Proceedings 2001, p 1412
24. Soper JT: Gestational trophoblastic disease. Obstet Gynecol 2006;108:176-187
25. Wang PH, Yuan CC, Tseng JY., et al: High risk gestational trophoblastic tumors: Analysis of clinical prognosis. Eur J Gynecol Oncol 1998:19:302-304
26. Jones W, Schneider J, Shapiro F, et al: Treatment of resistant gestational choriocarcinoma with Taxol: Report of two cases. Gynecol Oncol 1996;61:126-130
27. Marth C, Lang T, Widschwendter M, et al: Effects of Taxol on choriocarcinoma cells. Am J Obstet Gynecol 1995;173:1835-1842
28. Deicais RE, Miller W, Lurain J: The role of contraception in the development of post-molar gestational trophoblastic tumors. Obstet Gynecol 1991;78:221-226
29. Costa Helio LFF: Influence of oral contraceptives in the development of post-molar trophoblastic neoplasia: A systematic review. Gynecol Oncol 2006;100:579-585
30. Palmer JR, Kohorn E, Berkowitz R, et al: Oral contraceptive use and risk of gestational trophoblastic tumors. J Nat Cancer Inst 1999;91:635-640
31. Soper JT: Surgical therapy for gestational trophoblastic disease. J Reprod Med 1994;39:168-174
32. Lehman E, Morris M: Salvage surgery for chemorefractory gestational trophoblastic disease. J Clin Oncol 1994;12:2737-2742
33. Hammond CB, Weed JC Jr, Currie JL: The role of operation in the current therapy of gestational trophoblastic disease. Am J Obstet Gynecol 1980;136:844-858
34. Suzuka K, Matsui H, Iitsuka Y, et al: Adjuvant hysterectomy in low-risk gestational trophoblastic disease. Obstet Gynecol 2001;97:431-434
35. Biman KC, Nidhu RM, Tanmoy C: Gestational trophoblastic tumor at a tertiary level cancer center: A retrospective study. J Reprod Med 2006;11:875-878
36. Ali A: Effects of prophylactic chemotherapy for post-molar trophoblastic disease. Int J Obstet Gynecol 1990;32:39-41
37. Cortes-Charry R, Figueira LM, García-Barriola V, et al: Gestational trophoblastic neoplasia: Clinical trends in 8 years at Hospital Universitario de Caracas. J Reprod Med 2006;51: 888-891
38. Lurain JR, Quinn M, Murray J, et al: High-risk gestational trophoblastic tumors. J Reprod Med 1998;43:44-52
39. Mutch DG, Soper JT, Babcock CJ, et al: Recurrent gestational trophoblastic disease: Experience of the Southeastern Regional Trophoblastic Disease Center. Cancer 1990;66:978-982
40. Ngan HYS, Tam K-F, Lam K-W, et al: Relapsed gestational trophoblastic neoplasia: A 20-year experience. J Reprod Med 2006;10:829-834
41. Bianconi M, Jankilevich G, Otero S, et al: Successful salvage of a relapsed high-risk gestational trophoblastic neoplasia patient using capecitabine. Gynecol Oncol 2007;106:268-271
42. Berkowitz RS, Goldstein DP: Reproductive experience after complete and partial molar pregnancy and gestational trophoblastic disease. J Reprod Med 1991;36:3-8
43. Goldfarb J: Reproductive performance of patients after gestational trophoblastic disease. Semin Oncol 1995;22:193-197